Eli Lilly and Company is investing 4.8 billion euros to expand its Indiana manufacturing site.

The expansion aims to increase production of weight-loss and diabetes treatments Zepbound and Mounjaro, which contain tirzepatide.

A new factory is planned to open by 2026 to meet high demand for these medications.

Celebrity endorsements from Elon Musk and Oprah Winfrey have fueled demand for these treatments.

Analysts project the anti-obesity drug market could reach $100 billion by 2030.

Other pharmaceutical companies, like Novo Nordisk, are also expanding production.

Governor Eric Holcomb praised the investment as a significant boost to job creation in Indiana.

Total private-sector investments under President Joe Biden now total $30 billion.